Glenmark obtains FDA nod for generic Prolixin
Fluphenazine is a medication that treats mental health conditions that cause disruptive thoughts and nervousness.
Glenmark has received the Food and Drug Administration’s green light for fluphenazine hydrochloride tablets, 1 mg, 2.5 mg, 5 mg and 10 mg, which is the generic of Apothecon’s Prolixin.
Fluphenazine is a medication that treats mental health conditions that cause disruptive thoughts and nervousness.
Glenmark's generic Prolixin will be distributed in the United States by Glenmark Pharmaceuticals USA.
[Read more FDA grants Glenmark tentative approval for generic Enstilar]
Prolixin had a market value of approximately $18.1 million for the 12-month period ending September 2023, per IQVIA.
[Read more: Glenmark obtains FDA nod for generic Protopic]